Suppr超能文献

ERN GENTURIS 指南:关于错配修复缺陷诊断、遗传咨询、监测、生活质量和临床管理的建议。

ERN GENTURIS guidelines on constitutional mismatch repair deficiency diagnosis, genetic counselling, surveillance, quality of life, and clinical management.

机构信息

Institut Curie, Paris, France.

Gustave Roussy Cancer Center, Villejuif, France.

出版信息

Eur J Hum Genet. 2024 Dec;32(12):1526-1541. doi: 10.1038/s41431-024-01708-6. Epub 2024 Oct 17.

Abstract

Constitutional mismatch repair deficiency (CMMRD), first described 25 years ago, confers an extremely high and lifelong cancer risk, including haematologic, brain, and gastrointestinal tract malignancies, and is associated with several non-neoplastic features. Our understanding of this condition has improved and novel assays to assist CMMRD diagnosis have been developed. Surveillance protocols need adjustment taking into account recent observational prospective studies assessing their effectiveness. Response to immune checkpoint inhibitors and the effectiveness and toxicity of other treatments have been described. An update and merging of the different guidelines on diagnosis and clinical management of CMMRD into one comprehensive guideline was needed. Seventy-two expert members of the European Reference Network GENTURIS and/or the European care for CMMRD consortium and one patient representative developed recommendations for CMMRD diagnosis, genetic counselling, surveillance, quality of life, and clinical management based on a systematic literature search and comprehensive literature review and a modified Delphi process. Recommendations for the diagnosis of CMMRD provide testing criteria, propose strategies for CMMRD testing, and define CMMRD diagnostic criteria. Recommendations for surveillance cover each CMMRD-associated tumour type and contain information on starting age, frequency, and surveillance modality. Recommendations for clinical management cover cancer treatment, management of benign tumours or non-neoplastic features, and chemoprevention. Recommendations also address genetic counselling and quality of life. Based on existing guidelines and currently available data, we present 82 recommendations to improve and standardise the care of CMMRD patients in Europe. These recommendations are not meant to be prescriptive and may be adjusted based on individual decisions.

摘要

标题: 遗传性错配修复缺陷相关疾病诊治专家共识

摘要: 遗传性错配修复缺陷(CMMRD)是一种高外显率的常染色体隐性遗传病,由 MLH1、MSH2、MSH6 和 PMS2 等错配修复基因胚系致病性变异导致,具有极高的肿瘤易感性,可累及血液系统、中枢神经系统和胃肠道等多系统,还伴有多种非肿瘤性表现。近年来,随着对 CMMRD 认识的不断深入,其检测方法也在不断完善。本共识由欧洲 GENTURIS 参考网络和/或欧洲 CMMRD 协作网的 72 名专家成员和 1 名患者代表共同制定,旨在为 CMMRD 的诊断、遗传咨询、监测、生活质量和临床管理提供指导建议。该共识基于系统文献检索和全面文献复习,以及改良 Delphi 法,详细阐述了 CMMRD 的诊断、遗传咨询、监测、生活质量和临床管理的推荐意见。共识内容涵盖了 CMMRD 的诊断标准、基因检测策略、监测方案、治疗策略以及遗传咨询和生活质量等方面。本共识为欧洲 CMMRD 患者的诊治提供了全面、系统的指导建议,有助于提高诊治水平,改善患者预后。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e475/11607302/fc67124677f8/41431_2024_1708_Fig1_HTML.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验